277 related articles for article (PubMed ID: 18178950)
21. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
23. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.
van Diepen AT; Tomlinson GA; Jassal SV
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1266-71. PubMed ID: 22745277
[TBL] [Abstract][Full Text] [Related]
24. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
[TBL] [Abstract][Full Text] [Related]
25. Chlorhexidine for routine PD catheter exit-site care.
Olga B; Fotis Z; Margarita I; Sofia X; Konstantinos S
Int Urol Nephrol; 2016 Sep; 48(9):1543-6. PubMed ID: 27432412
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.
Thodis E; Passadakis P; Ossareh S; Panagoutsos S; Vargemezis V; Oreopoulos DG
Int J Artif Organs; 2003 Aug; 26(8):698-714. PubMed ID: 14521167
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
Chen SS; Sheth H; Piraino B; Bender F
Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
[TBL] [Abstract][Full Text] [Related]
28. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
[TBL] [Abstract][Full Text] [Related]
29. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
Davenport A;
J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
[TBL] [Abstract][Full Text] [Related]
30. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis.
Xu G; Tu W; Xu C
Nephrol Dial Transplant; 2010 Feb; 25(2):587-92. PubMed ID: 19679557
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
Strippoli GF; Tong A; Johnson D; Schena FP; Craig JC
Cochrane Database Syst Rev; 2004 Oct; (4):CD004679. PubMed ID: 15495124
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
[TBL] [Abstract][Full Text] [Related]
33. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.
Pommer W; Brauner M; Westphale HJ; Brunkhorst R; Krämer R; Bundschu D; Höffken B; Steinhauer HB; Schümann E; Lüttgen FM; Schillinger-Pokorny E; Schaefer F; Wende R; Offner G; Näther S; Osten B; Zimmering M; Ehrich JH; Kehn M; Mansmann U; Grosse-Siestrup C
Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444
[TBL] [Abstract][Full Text] [Related]
34. Prevention of catheter related infections in patients on CAPD.
Thodis E; Passadakis P; Vargemezis V; Oreopoulos DG
Int J Artif Organs; 2001 Oct; 24(10):671-82. PubMed ID: 11817317
[TBL] [Abstract][Full Text] [Related]
35. Clinical Value of Screening Peritoneal Dialysis Patients for Bacterial Colonization or Contamination.
Parthasarathy R; Kashem T; NicFhogartaigh C; Melzer M; Fan SL
Perit Dial Int; 2019; 39(2):126-133. PubMed ID: 30739095
[TBL] [Abstract][Full Text] [Related]
36. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
Casey M; Taylor J; Clinard P; Graham A; Mauck V; Spainhour L; Brown P; Burkart J
Perit Dial Int; 2000; 20(5):566-8. PubMed ID: 11117248
[No Abstract] [Full Text] [Related]
37. Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey.
Kopriva-Altfahrt G; König P; Mündle M; Prischl F; Roob JM; Wiesholzer M; Vychytil A; ; Arneitz K; Karner A; Artes R; Wolf E; Auinger M; Pawlak A; Fraberger J; Hofbauer S; Galvan G; Salmhofer H; Pichler B; Wazel M; Gruber M; Thonhofer A; Hager A; Malajner S; Heiss S; Braunsteiner T; Zweiffler M; König P; Rudnicki M; Kogler R; Kohlhauser D; Wiesinger T; Kopriva-Altfahrt G; Moser E; Kotanko P; Loibner H; Nitz H; Miska HJ; Wenzel R; Wölfer M; Mündle M; Breuss H; Hölzl B; Prischi F; Schmekal B; Riener EM; Roob JM; Wonisch W; Vikydal R; Vychytil A; Frank B; Wieser C; Wiesholzer M; Pokorny K
Perit Dial Int; 2009; 29(3):330-9. PubMed ID: 19458307
[TBL] [Abstract][Full Text] [Related]
38. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: prophylaxis for exit site/tunnel infections using mupirocin.
Caring for Australians with Renal Impairment (CARI)
Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S86-90. PubMed ID: 15469567
[No Abstract] [Full Text] [Related]
39. Dialysis: The importance of peritoneal catheter exit-site care.
Piraino B
Nat Rev Nephrol; 2010 May; 6(5):259-60. PubMed ID: 20424630
[No Abstract] [Full Text] [Related]
40. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Was it effective?
Piraino B
Nephrol Dial Transplant; 2010 Feb; 25(2):349-52. PubMed ID: 19934078
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
